Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease
Research output: Contribution to journal › Journal article › Research › peer-review
The efficacy of proton-pump inhibitor (PPI) therapy often is assessed to determine whether patients' symptoms are acid-related and if patients have gastroesophageal reflux disease (GERD), although the accuracy of this approach is questionable. We evaluated the diagnostic performance of the PPI test, in conjunction with other tests, for the diagnosis of GERD.
Original language | English |
---|---|
Journal | Clinical Gastroenterology and Hepatology |
Volume | 10 |
Issue number | 12 |
Pages (from-to) | 1360-6 |
Number of pages | 7 |
ISSN | 1542-3565 |
DOIs | |
Publication status | Published - Dec 2012 |
- Clinical Medicine, Esomeprazole Sodium, Esophageal pH Monitoring, Esophagoscopy, Gastroesophageal Reflux, Humans, Placebos, Primary Health Care, Proton Pump Inhibitors, Questionnaires, Sensitivity and Specificity, Single-Blind Method
Research areas
ID: 47892215